Second Bellwether Ordered in Abilify Gambling Lawsuit

Post on behalf of Thomas J. Ueberschaer PA on Wednesday August 29, 2018

A second set of cases in the ongoing Abilify Gambling Multi District Litigation have been designated for bellwether trials. Forty cases were selected at random on August 8th by Chief Judge M. Casey Rodgers in an order. The order also explains that Plaintiffs and Defendants would have 14 days to each strike five cases from the pool of randomly selected ones.

For the 30 remaining cases, Plaintiffs are required to submit completed Plaintiff Fact Sheets (PFS) by October 12, 2018. Plaintiff Fact Sheets are informational documents used to collect basic discoverable information that is to be shared with defense counsel. In addition to the PFSs, plaintiffs are also required to submit other documentation related to evidence of damages, which includes items such as medical and financial records, and authorizations required for the acquisition of other information.

The process of striking cases from the pool will continue until the plaintiff and defendant have each reduced their pool of possible trial cases to five (ten total).

“The Court is continuing to consider the possibility of consolidating some number of cases for trial and trying the remaining cases individually,” the order reads. “At this time, the Court is leaning towards conducting a consolidated trail. However, before making a final decision on consolidation, the Court will allow briefing on the issue and, if applicable, on the question of which specific cases will be consolidated.”

About Abilify Lawsuits

Abilify (Aripiprazole) is a prescription drug approved for use in the treatment of schizophrenia, major depressive disorder, and bipolar disorder.

The United States Food and Drug Administration (FDA) issued an order in May 2016 that Abilify have new warnings added to its label that speak to the risk of compulsive behaviors, including dangerous gambling addiction. This followed mounting reports of disorders in the FDA’s database, with the overwhelming majority of being related to gambling addiction.

Since the time of FDA’s order for a label update, thousands of Abilify lawsuits have been filed claiming that Abilify is responsible for dangerous episodes of gambling addiction and other impulse-control related disorders.

If you or a loved one were prescribed Abilify and suffered injuries or began showing signs of gambling addiction, you have legal rights. Contact our law firm today to discuss any potential claims in a free initial consultation.

Call toll free 800-435-8778.

Share On: